In our study, viperin ASO protected HFD- fed mice from hepatic steatosis and hyperlipidaemia by reducing liver weight (Figure 6A), plasma TG (Figure 6B) and hepatic lipid content (Figure 6C). Here, RSAD2 is linked to hyperlipidemia.